# A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study

> **NCT01554995** · PHASE1 · COMPLETED · sponsor: **LigaChem Biosciences, Inc.** · enrollment: 70 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LCB01-0371
- **DRUG:** Linezolid

## Key facts

- **NCT ID:** NCT01554995
- **Lead sponsor:** LigaChem Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-12
- **Final completion:** 2013-02
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2014-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01554995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01554995, "A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01554995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*